0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Metagenomics Market by Product (Instrument & Software and Consumable), Technology (Sequencing and Bioinformatics), and Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, and Agriculture) - Global Opportunity Analysis and Industry Forecast, 2017-2024
Published Date: November 2019
|
Report Code: ALLI-Auto-0V276
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Metagenomics Market by Product Instrument Software and Consumable Technology Sequencing and Bioinformatics and Application Infectious Disease Diagnosis Environmental Remediation Gut Microbe Characterization Biotechnology Biofuel and Agriculture Global Opportunity Analysis and Industry Forecast 2017 2024
BUY CHAPTERS

Metagenomics Market by Product (Instrument & Software and Consumable), Technology (Sequencing and Bioinformatics), and Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, and Agriculture) - Global Opportunity Analysis and Industry Forecast, 2017-2024

Code: ALLI-Auto-0V276
Report
November 2019
Pages:231
Allied Market Research
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

 

Metagenomics Market 

The global metagenomics market was valued at USD 176 Million in 2017 and is expected to reach USD 523 Million by 2024 at a CAGR of 16.8% from 2018 to 2024.Metagenomics is the study of genomes collectively in a microbial community. This process involves cloning and analyzing the genomes without culturing the organisms in the community.

Metagenomics Market Trends

Increase in advancements regarding DNA sequencing and rise in expansion of metagenomics applications drive the growth of the global metagenomics market. However, dearth of skilled professionals coupled with the rise in concerns regarding standardization and accuracy of sequencing based diagnostic testing hampers the market growth. Moreover, developing nations offer profitable opportunities for metagenomic sequencing product manufacturers.
 
The global metagenomics market is segmented based on technology, product, application, and region. Based on technology, the market is bifurcated into sequencing and bioinformatics. By product, the market is divided into instrument & software and consumable. On the basis of application, the market is classified into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture. As per region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
 

Based on product, the global metagenomics market is categorized into instrument & software and consumable. The consumable segment accounted for a major share in the global market in 2017 and is expected to maintain this dominance throughout the forecast period. High adoption of consumables in the pre-sequencing, which is one of the most important steps in the overall metagenomic sequencing protocol, has contributed to the dominant position of this segment in the market. In addition, maximum utilization of consumables ensures that the DNA involved in the metagenomic analysis would be a representative of all cells in the sample and ideal for generation of genomic libraries. Whereas, the instrument & software segment is expected to register the highest growth rate during 2018-2024, owing to the continuous evolution in the development of software packages and instruments utilized in the metagenomic studies.

Application Segment Review

Based on application, the global metagenomics market is segmented into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture. The gut microbe characterization segment  dominated the global market in 2017 and is expected to maintain this dominance throughout the forecast period. The human intestinal microbiota is a homeostatic ecosystem, which has a significant impact on human health, and the disruption of this equilibrium leads to increased susceptibility to infections by various pathogens. In addition, the application of metagenomics has aided in identifying bacterial pathogens such as Shiga Toxin-producing E. coli (STEC) infection, which is associated with foodborne disease outbreaks. Whereas, the infectious disease diagnosis segment is expected to grow at the fastest pace during the forecast period. This is attributed to the increasing popularity of metagenomic technologies among clinical researchers, which aids in identification of responsible bacterial pathogens in several infectious diseases.

Geography Segment Review 

Region-wise, the global metagenomics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the major contributor in terms of revenue in 2017 and is anticipated to maintain this dominance throughout the forecast period. This is attributed to the increasing implementation of DNA sequencing across metagenomic applications in this region. In addition, rapid adoption of novel sequencing technologies in this region has contributed to its dominance. Whereas, the Asia-Pacific region is estimated to register the highest CAGR during the forecast period, owing to the considerable patient population base along with the continuously evolving healthcare infrastructure across countries in this region.

The report provides a comprehensive analysis of the key players operating in the global metagenomics market, such as Agilent Technologies, Inc., Enterome SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Qiagen N.V., Swift Biosciences, Inc., and Thermo Fisher Scientific, Inc. The other players operating in the global metagenomics market include Siemens AG, ZS Genetics, Inc., Abbott Laboratories, Beckman Coulter, LI-COR, Genomatix GmbH, Beijing Genomics Institute, and Pieriandx.

By Type 

  • Instrument & software
  • Consumable

By Product

  • Sequencing
  • Bioinformatics

By Application

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Taiwan
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

By Company

  • Agilent Technologies, Inc.
  • Enterome SA
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Swift Biosciences, Inc.
  • Thermo Fisher Scientific, Inc.
The other players in the value chain include (profiles not included in the report): 
  • Siemens AG
  • ZS Genetics, Inc.
  • Abbott Laboratories
  • Beckman Coulter
  • LI-COR
  • Genomatix GmbH
  • Beijing Genomics Institute
  • Pieriandx

TABLE OF CONTENT

 
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
 
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
 
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.3. Top player positioning, 2017
3.4. Porters Five Forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in advancements regarding DNA sequencing
3.5.1.2. Increase in the scientific collaboration between metagenomic experiments and computing technologies
3.5.1.3. Rise in expansion of metagenomics applications
3.5.2. Restraints
3.5.2.1. Dearth of skilled professionals
3.5.2.2. Rise in the concerns regarding standardization and accuracy of sequencing based diagnostic testing
3.5.3. Opportunity
3.5.3.1. Emerging nations offer profitable opportunities for metagenomic sequencing product manufacturers
 
CHAPTER 4: METAGENOMICS MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Sequencing
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Bioinformatics
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
 
CHAPTER 5: METAGENOMICS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Consumables
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Instrument & Software
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
 
CHAPTER 6: METAGENOMICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Infectious Disease Diagnosis
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Environmental Remediation
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Gut Microbe Characterization
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Biotechnology
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country
6.6. Biofuel
6.6.1. Market size and forecast, by region
6.6.2. Market analysis, by country
6.7. Agriculture
6.7.1. Market size and forecast, by region
6.7.2. Market analysis, by country
 
CHAPTER 7: METAGENOMICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S. market size and forecast, by product
7.2.2.2. U.S. market size and forecast, by technology
7.2.2.3. U.S. market size and forecast, by application
7.2.2.4. Canada market size and forecast, by product
7.2.2.5. Canada market size and forecast, by technology
7.2.2.6. Canada market size and forecast, by application
7.2.2.7. Mexico market size and forecast, by product
7.2.2.8. Mexico market size and forecast, by technology
7.2.2.9. Mexico market size and forecast, by application
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by technology
7.2.5. North America market size and forecast, by application
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. Germany market size and forecast, by product
7.3.2.2. Germany market size and forecast, by technology
7.3.2.3. Germany market size and forecast, by application
7.3.2.4. France market size and forecast, by product
7.3.2.5. France market size and forecast, by technology
7.3.2.6. France market size and forecast, by application
7.3.2.7. UK market size and forecast, by product
7.3.2.8. UK market size and forecast, by technology
7.3.2.9. UK market size and forecast, by application
7.3.2.10. Italy market size and forecast, by product
7.3.2.11. Italy market size and forecast, by technology
7.3.2.12. Italy market size and forecast, by application
7.3.2.13. Spain market size and forecast, by product
7.3.2.14. Spain market size and forecast, by technology
7.3.2.15. Spain market size and forecast, by application
7.3.2.16. Rest of Europe market size and forecast, by product
7.3.2.17. Rest of Europe market size and forecast, by technology
7.3.2.18. Rest of Europe market size and forecast, by application
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by technology
7.3.5. Europe market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan market size and forecast, by product
7.4.2.2. Japan market size and forecast, by technology
7.4.2.3. Japan market size and forecast, by application
7.4.2.4. China market size and forecast, by product
7.4.2.5. China market size and forecast, by technology
7.4.2.6. China market size and forecast, by application
7.4.2.7. Australia market size and forecast, by product
7.4.2.8. Australia market size and forecast, by technology
7.4.2.9. Australia market size and forecast, by application
7.4.2.10. India market size and forecast, by product
7.4.2.11. India market size and forecast, by technology
7.4.2.12. India market size and forecast, by application
7.4.2.13. South Korea market size and forecast, by product
7.4.2.14. South Korea market size and forecast, by technology
7.4.2.15. South Korea market size and forecast, by application
7.4.2.16. Taiwan market size and forecast, by product
7.4.2.17. Taiwan market size and forecast, by technology
7.4.2.18. Taiwan market size and forecast, by application
7.4.2.19. Rest of Asia-Pacific market size and forecast, by product
7.4.2.20. Rest of Asia-Pacific market size and forecast, by technology
7.4.2.21. Rest of Asia-Pacific market size and forecast, by application
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by technology
7.4.5. Asia-Pacific market size and forecast, by application
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil market size and forecast, by product
7.5.2.2. Brazil market size and forecast, by technology
7.5.2.3. Brazil market size and forecast, by application
7.5.2.4. Turkey market size and forecast, by product
7.5.2.5. Turkey market size and forecast, by technology
7.5.2.6. Turkey market size and forecast, by application
7.5.2.7. Saudi Arabia market size and forecast, by product
7.5.2.8. Saudi Arabia market size and forecast, by technology
7.5.2.9. Saudi Arabia market size and forecast, by application
7.5.2.10. South Africa market size and forecast, by product
7.5.2.11. South Africa market size and forecast, by technology
7.5.2.12. South Africa market size and forecast, by application
7.5.2.13. Rest of LAMEA market size and forecast, by product
7.5.2.14. Rest of LAMEA market size and forecast, by technology
7.5.2.15. Rest of LAMEA market size and forecast, by application
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by technology
7.5.5. LAMEA market size and forecast, by application
 
CHAPTER 8: COMPANY PROFILES
8.1. Agilent Technologies, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Enterome SA
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Key strategic moves and developments
8.3. F. Hoffmann-La Roche Ltd.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Illumina, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Oxford Nanopore Technologies Ltd.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.6. Pacific Biosciences of California, Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. PerkinElmer Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. QIAGEN N.V.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.9. Swift Biosciences Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. Thermo Fisher Scientific, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and development

LIST OF TABLES & FIGURES

 
TABLE 01. GLOBAL METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 02. METAGENOMICS MARKET FOR SEQUENCING, BY REGION, 2017-2024 ($MILLION)
TABLE 03. METAGENOMICS MARKET FOR BIOINFORMATICS, BY REGION, 2017-2024 ($MILLION)
TABLE 04. GLOBAL METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 05. GLOBAL METAGENOMICS MARKET FOR CONSUMABLES, BY REGION, 2017-2024 ($MILLION)
TABLE 06. GLOBAL METAGENOMICS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2017-2024 ($MILLION)
TABLE 07. GLOBAL METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 08. METAGENOMICS MARKET FOR INFECTIOUS DISEASE DIAGNOSIS, BY REGION, 2017-2024 ($MILLION)
TABLE 09. METAGENOMICS MARKET FOR ENVIRONMENTAL REMEDIATION, BY REGION, 2017-2024 ($MILLION)
TABLE 10. METAGENOMICS MARKET FOR GUT MICROBE CHARACTERIZATION, BY REGION, 2017-2024 ($MILLION)
TABLE 11. METAGENOMICS MARKET FOR BIOTECHNOLOGY, BY REGION, 2017-2024 ($MILLION)
TABLE 12. METAGENOMICS MARKET FOR BIOFUEL, BY REGION, 2017-2024 ($MILLION)
TABLE 13. METAGENOMICS MARKET FOR AGRICULTURE, BY REGION, 2017-2024 ($MILLION)
TABLE 14. METAGENOMICS MARKET, BY REGION, 2017-2024 ($MILLION)
TABLE 15. NORTH AMERICA METAGENOMICS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 16. U.S. METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 17. U.S. METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 18. U.S. METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 19. CANADA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 20. CANADA METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 21. CANADA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 22. MEXICO METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 23. MEXICO METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 24. MEXICO METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 25. NORTH AMERICA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 26. NORTH AMERICA METAGENOMICS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 27. NORTH AMERICA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 28. EUROPE METAGENOMICS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 29. GERMANY METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 30. GERMANY METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 31. GERMANY METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 32. FRANCE METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 33. FRANCE METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 34. FRANCE METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 35. UK METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 36. UK METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 37. UK METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 38. ITALY METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 39. ITALY METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 40. ITALY METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 41. SPAIN METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 42. SPAIN METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 43. SPAIN METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 44. REST OF EUROPE METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 45. REST OF EUROPE METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 46. REST OF EUROPE METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 47. EUROPE METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 48. EUROPE METAGENOMICS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 49. EUROPE METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 50. ASIA-PACIFIC METAGENOMICS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 51. JAPAN METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 52. JAPAN METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 53. JAPAN METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 54. CHINA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 55. CHINA METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 56. CHINA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 57. AUSTRALIA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 58. AUSTRALIA METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 59. AUSTRALIA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 60. INDIA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 61. INDIA METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 62. INDIA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 63. SOUTH KOREA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 64. SOUTH KOREA METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 65. SOUTH KOREA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 66. TAIWAN METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 67. TAIWAN METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 68. TAIWAN METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 72. ASIA-PACIFIC METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 73. ASIA-PACIFIC METAGENOMICS MARKET, BY TECHNOLGY, 2017-2024 ($MILLION)
TABLE 74. ASIA-PACIFIC METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 75. LAMEA METAGENOMICS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 76. BRAZIL METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 77. BRAZIL METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 78. BRAZIL METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 79. TURKEY METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 80. TURKEY METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 81. TURKEY METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 82. SAUDI ARABIA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 83. SAUDI ARABIA METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 84. SAUDI ARABIA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 85. SOUTH AFRICA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 86. SOUTH AFRICA METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 87. SOUTH AFRICA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 88. REST OF LAMEA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 89. REST OF LAMEA METAGENOMICS MARKET, BY TECHNOLOGY, 2017-2024 ($MILLION)
TABLE 90. REST OF LAMEA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 91. LAMEA METAGENOMICS MARKET, BY PRODUCT, 2017-2024 ($MILLION)
TABLE 92. LAMEA METAGENOMICS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 93. LAMEA METAGENOMICS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
TABLE 94. AGILENT: COMPANY SNAPSHOT
TABLE 95. AGILENT: OPERATING SEGMENTS
TABLE 96. AGILENT: PRODUCT PORTFOLIO
TABLE 97. ENTEROME: COMPANY SNAPSHOT
TABLE 98. ENTEROME: PRODUCT PORTFOLIO
TABLE 99. ROCHE: COMPANY SNAPSHOT
TABLE 100. ROCHE: OPERATING SEGMENTS
TABLE 101. ROCHE: PRODUCT PORTFOLIO
TABLE 102. ILLUMINA: COMPANY SNAPSHOT
TABLE 103. ILLUMINA: OPERATING SEGMENTS
TABLE 104. ILLUMINA: PRODUCT PORTFOLIO
TABLE 105. OXFORD NANOPORE: COMPANY SNAPSHOT
TABLE 106. OXFORD NANOPORE: PRODUCT PORTFOLIO
TABLE 107. PACBIO: COMPANY SNAPSHOT
TABLE 108. PACBIO: PRODUCT PORTFOLIO
TABLE 109. PERKINELMER: COMPANY SNAPSHOT
TABLE 110. PERKINELMER: OPERATING SEGMENTS
TABLE 111. PERKINELMER: PRODUCT PORTFOLIO
TABLE 112. QIAGEN: COMPANY SNAPSHOT
TABLE 113. QIAGEN: PRODUCT PORTFOLIO
TABLE 114. SWIFT BIOSCIENCES: COMPANY SNAPSHOT
TABLE 115. SWIFT BIOSCIENCES: OPERATING SEGMENTS
TABLE 116. SWIFT BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 117. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 118. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 119. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO FIGURE 01. METAGENOMICS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN METAGENOMICS MARKET, 2017
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2014-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018*
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. HIGH BARGAINING POWER OF BUYERS
FIGURE 09. LOW THREAT OF SUBSTITUTION
FIGURE 10. MODERATE THREAT OF NEW ENTRANT
FIGURE 11. MODERATE COMPETITIVE RIVALRY
FIGURE 12. GLOBAL METAGENOMICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 13. METAGENOMICS MARKET, BY TECHNOLOGY
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SEQUENCING MARKET, BY COUNTRY, 2017 & 2024 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICSMARKET, BY COUNTRY, 2017 & 2024 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF METAGENOMICS MARKET FOR CONSUMABLES, BY COUNTRY, 2017 & 2024 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF METAGENOMICS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2017 & 2024 (%)
FIGURE 18. METAGENOMICS MARKET, BY APPLICATION
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF INFECTIOUS DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2017 & 2024 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ENVIRONMENTAL REMEDIATION MARKET, BY COUNTRY, 2017 & 2024 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GUT MICROBE CHARACTERIZATION MARKET, BY COUNTRY, 2017 & 2024 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY MARKET, BY COUNTRY, 2017 & 2024 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF BIOFUEL MARKET, BY COUNTRY, 2017 & 2024 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF AGRICULTURE MARKET, BY COUNTRY, 2017 & 2024 (%)
FIGURE 25. AGILENT: NET SALES, 2015-2017 ($MILLION)
FIGURE 26. AGILENT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 27. AGILENT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 28. ROCHE: NET SALES, 2015-2017 ($MILLION)
FIGURE 29. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 30. ILLUMINA: NET SALES, 2015-2017 ($MILLION)
FIGURE 31. ILLUMINA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 32. ILLUMINA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 33. PACBIO: NET SALES, 2015-2017 ($MILLION)
FIGURE 34. PACBIO: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 35. PERKINELMER: NET SALES, 2015-2017 ($MILLION)
FIGURE 36. PERKINELMER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. PERKINELMER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 38. QIAGEN: NET SALES, 2015-2017 ($MILLION)
FIGURE 39. QIAGEN: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 40. QIAGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 41. THERMO FISHER SCIENTIFIC: REVENUE, 2015-2017 ($MILLION)
FIGURE 42. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 43. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5370

This license allows only one user to access the PDF.
Electronic (PDF)

$6450

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8995

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS